Experimental and Theoretical Insights on Chemopreventive Effect of the Liposomal Thymoquinone Against Benzo[a]pyrene-Induced Lung Cancer in Swiss Albino Mice

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Ruppert A-M, Amrioui F, Fallet V. [Risk factors and prevention of lung cancer]. Rev Prat. 2020;70:852–856. French.
   PubMedGoogle Scholar
• McFarland DC. A response to “Psychological symptoms and survival in patients with metastatic lung cancer: smoking must be the first concern!”. Psycho Oncol. 2020;29:1504–1505. doi:10.1002/pon.5405
   PubMed Web of Science ®Google Scholar
• Sasco AJ, Secretan MB, Straif K. Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer. 2004;45:S3–S9. doi:10.1016/j.lungcan.2004.07.998
   PubMed Web of Science ®Google Scholar
• Shen H, Spitz MR, Qiao Y, et al. Smoking, DNA repair capacity and risk of nonsmall cell lung cancer. Int J Cancer. 2003;107:84–88. doi:10.1002/ijc.11346
   PubMed Web of Science ®Google Scholar
• Zou X, Fu Y, Wu D, Liu J, Xiao Y, Huang H. [Establishment of mouse lung cancer model induced by benzo[a]pyrene dynamic inhalation exposure]. Wei Sheng Yan Jiu. 2020;49:486–490. Chinese.
   PubMedGoogle Scholar
• Ceppi M, Munnia A, Cellai F, Bruzzone M, Peluso MEM. Linking the generation of DNA adducts to lung cancer. Toxicology. 2017;390:160–166. doi:10.1016/j.tox.2017.09.011
   PubMed Web of Science ®Google Scholar
• Osborne MR, Brookes P, Beland FA, Harvey RG. The reaction of (±)-7α, 8β-dihydroxy-9β, 10β-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene with DNA. Int J Cancer. 1976;18:362–368. doi:10.1002/ijc.2910180315
   PubMed Web of Science ®Google Scholar
• Pucci C, Martinelli C, Ciofani G. Innovative approaches for cancer treatment: current perspectives and new challenges. EcancerMedicalscience. 2019;13. doi:10.3332/ecancer.2019.961
   PubMed Web of Science ®Google Scholar
• Charmsaz S, Prencipe M, Kiely M, Pidgeon G, Collins D. Innovative technologies changing cancer treatment. Cancers. 2018;10:208. doi:10.3390/cancers10060208
   PubMed Web of Science ®Google Scholar
• Hameed R, Khan A, Khan S, Perveen S. Computational approaches towards kinases as attractive targets for anticancer drug discovery and development. Anticancer Agents Med Chem. 2019;19:592–598. doi:10.2174/1871520618666181009163014
   PubMed Web of Science ®Google Scholar
• Thomford N, Senthebane D, Rowe A, et al. Natural products for drug discovery in the 21st century: innovations for novel drug discovery. Int J Mol Sci. 2018;19:1578. doi:10.3390/ijms19061578
   PubMed Web of Science ®Google Scholar
• Wolfender J-L, Litaudon M, Touboul D, Queiroz EF. Innovative omics-based approaches for prioritisation and targeted isolation of natural products – new strategies for drug discovery. Nat Prod Rep. 2019;36:855–868. doi:10.1039/C9NP00004F
   PubMed Web of Science ®Google Scholar
• Chopra B, Dhingra AK. Natural products: a lead for drug discovery and development. Phytother Res. 2021;35:4660–4702. doi:10.1002/ptr.7099
   PubMed Web of Science ®Google Scholar
• Patra S, Pradhan B, Nayak R, et al. Dietary polyphenols in chemoprevention and synergistic effect in cancer: clinical evidences and molecular mechanisms of action. Phytomedicine. 2021;90:153554. doi:10.1016/j.phymed.2021.153554
   PubMed Web of Science ®Google Scholar
• Ma L, Zhang M, Zhao R, Wang D, Ma Y, Li A. Plant natural products: promising resources for cancer chemoprevention. Molecules. 2021;27:26. doi:10.3390/molecules26040933
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod. 2020;83:770–803. doi:10.1021/acs.jnatprod.9b01285
   PubMed Web of Science ®Google Scholar
• de Kok TM, van Breda SG, Manson MM. Mechanisms of combined action of different chemopreventive dietary compounds: a review. Eur J Nutr. 2008;47(Suppl 2):51–59. doi:10.1007/s00394-008-2006-y
   PubMed Web of Science ®Google Scholar
• Malik S, Singh A, Negi P, Kapoor VK. Thymoquinone: a small molecule from nature with high therapeutic potential. Drug Discov Today. 2021;26:2716–2725. doi:10.1016/j.drudis.2021.07.013
   PubMed Web of Science ®Google Scholar
• Gali-Muhtasib H, Roessner A, Schneider-Stock R. Thymoquinone: a promising anti-cancer drug from natural sources. Int J Biochem Cell Biol. 2006;38:1249–1253. doi:10.1016/j.biocel.2005.10.009
   PubMed Web of Science ®Google Scholar
• Khan MA, Younus H. Thymoquinone shows the diverse therapeutic actions by modulating multiple cell signaling pathways: single drug for multiple targets. Curr Pharm Biotechnol. 2018;19:934–945. doi:10.2174/1389201019666181113122009
   PubMed Web of Science ®Google Scholar
• Khader M, Eckl PM. Thymoquinone: an emerging natural drug with a wide range of medical applications. Iran J Basic Med Sci. 2014;17:950–957.
   PubMed Web of Science ®Google Scholar
• Botnick I, Xue W, Bar E, et al. Distribution of primary and specialized metabolites in Nigella sativa seeds, a spice with vast traditional and historical uses. Molecules. 2012;17:10159–10177. doi:10.3390/molecules170910159
   PubMed Web of Science ®Google Scholar
• Ansary J, Giampieri F, Forbes-Hernandez TY, et al. Nutritional value and preventive role of Nigella sativa L. and its main component thymoquinone in cancer: an evidenced-based review of preclinical and clinical studies. Molecules. 2021;26:2108. doi:10.3390/molecules26082108
   PubMed Web of Science ®Google Scholar
• Asaduzzaman khan M, Tania M, Fu S, Fu J. Thymoquinone, as an anticancer molecule: from basic research to clinical investigation. Oncotarget. 2017;8:51907–51919. doi:10.18632/oncotarget.17206
   PubMedGoogle Scholar
• Rathore C, Rathbone MJ, Chellappan DK, et al. Nanocarriers: more than tour de force for thymoquinone. Expert Opin Drug Deliv. 2020;17:479–494. doi:10.1080/17425247.2020.1730808
   PubMed Web of Science ®Google Scholar
• Salmani J, Asghar S, Lv H, Zhou J. Aqueous solubility and degradation kinetics of the phytochemical anticancer thymoquinone; probing the effects of solvents, ph and light. Molecules. 2014;19:5925–5939. doi:10.3390/molecules19055925
   PubMed Web of Science ®Google Scholar
• Khan A, Alsahli MA, Aljasir MA, et al. Safety, stability, and therapeutic efficacy of long-circulating TQ-incorporated liposomes: implication in the treatment of lung cancer. Pharmaceutics. 2022;14:153. doi:10.3390/pharmaceutics14010153
   PubMed Web of Science ®Google Scholar
• Allemailem KS, Alnuqaydan AM, Almatroudi A, et al. Safety and therapeutic efficacy of thymoquinone-loaded liposomes against drug-sensitive and drug-resistant Acinetobacter baumannii. Pharmaceutics. 2021;14:13. doi:10.3390/pharmaceutics13050677
   PubMed Web of Science ®Google Scholar
• Khan MA, Aljarbou AN, Khan A, Younus H. Liposomal thymoquinone effectively combats fluconazole-resistant Candida albicans in a murine model. Int J Biol Macromol. 2015;76:203–208. doi:10.1016/j.ijbiomac.2015.02.015
   PubMed Web of Science ®Google Scholar
• Odeh F, Ismail SI, Abu-Dahab R, Mahmoud IS, Al Bawab A. Thymoquinone in liposomes: a study of loading efficiency and biological activity towards breast cancer. Drug Deliv. 2012;19:371–377. doi:10.3109/10717544.2012.727500
   PubMed Web of Science ®Google Scholar
• Odeh F, Naffa R, Azzam H, et al. Co-encapsulation of thymoquinone with docetaxel enhances the encapsulation efficiency into PEGylated liposomes and the chemosensitivity of MCF7 breast cancer cells to docetaxel. Heliyon. 2019;5:e02919. doi:10.1016/j.heliyon.2019.e02919
   PubMed Web of Science ®Google Scholar
• Patel HM, Ryman BE. Oral administration of insulin by encapsulation within liposomes. FEBS Lett. 1976;62:60–63. doi:10.1016/0014-5793(76)80016-6
   PubMed Web of Science ®Google Scholar
• Khan I, Gothwal A, Sharma AK, Qayum A, Singh SK, Gupta U. Biodegradable nano-architectural PEGylated approach for the improved stability and anticancer efficacy of bendamustine. Int J Biol Macromol. 2016;92:1242–1251. doi:10.1016/j.ijbiomac.2016.08.004
   PubMed Web of Science ®Google Scholar
• Minato S, Iwanaga K, Kakemi M, Yamashita S, Oku N. Application of polyethyleneglycol (PEG)-modified liposomes for oral vaccine: effect of lipid dose on systemic and mucosal immunity. J Control Release. 2003;89:189–197. doi:10.1016/s0168-3659(03)00093-2
   PubMed Web of Science ®Google Scholar
• Gabizon A, Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci. 1988;85:6949–6953. doi:10.1073/pnas.85.18.6949
   PubMed Web of Science ®Google Scholar
• Slepushkin V, Simões S, de Lima MCP, Düzgüneş N. Sterically stabilized ph-sensitive liposomes. Methods Enzymol. 2004;387:134–147. doi:10.1016/S0076-6879(04)87008-3
   PubMed Web of Science ®Google Scholar
• Woodle MC, Lasic DD. Sterically stabilized liposomes. Biochim Biophys Acta. 1992;1113:171–199. doi:10.1016/0304-4157(92)90038-c
   PubMed Web of Science ®Google Scholar
• Shahraki N, Mehrabian A, Amiri-Darban S, Moosavian SA, Jaafari MR. Preparation and characterization of PEGylated liposomal Doxorubicin targeted with leptin-derived peptide and evaluation of their anti-tumor effects, in vitro and in vivo in mice bearing C26 colon carcinoma. Colloids Surf B Biointerfaces. 2021;200:111589. doi:10.1016/j.colsurfb.2021.111589
   PubMed Web of Science ®Google Scholar
• Mozar FS, Chowdhury EH. Impact of PEGylated nanoparticles on tumor targeted drug delivery. Curr Pharm Des. 2018;24:3283–3296. doi:10.2174/1381612824666180730161721
   PubMed Web of Science ®Google Scholar
• Pozzi D, Colapicchioni V, Caracciolo G, et al. Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells. Nanoscale. 2014;6:2782–2792. doi:10.1039/c3nr05559k
   PubMed Web of Science ®Google Scholar
• Chow T-H, Lin -Y-Y, Hwang -J-J, et al. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model. Anticancer Res. 2009;29:2111–2120.
   PubMed Web of Science ®Google Scholar
• Pang X, Jiang Y, Xiao Q, Leung AW, Hua H, Xu C. pH-responsive polymer-drug conjugates: design and progress. J Control Release. 2016;222:116–129. doi:10.1016/j.jconrel.2015.12.024
   PubMed Web of Science ®Google Scholar
• Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17:20–37. doi:10.1038/nrc.2016.108
   PubMed Web of Science ®Google Scholar
• Khan A, Aljarbou AN, Aldebasi YH, et al. Fatty acid synthase (FASN) siRNA-encapsulated-Her-2 targeted fab’-immunoliposomes for gene silencing in breast cancer cells. Int J Nanomedicine. 2020;15:5575–5589. doi:10.2147/IJN.S256022
   PubMed Web of Science ®Google Scholar
• Khan A, Aljarbou AN, Khan S, Khan MA. Her-2-directed systemic delivery of fatty acid synthase (FASN) siRNA with novel liposomal carrier systems in the breast cancer mouse model. J Drug Target. 2022;1–12. doi:10.1080/1061186X.2022.2038613
   Web of Science ®Google Scholar
• Khan MA, Aldebasi YH, Alsuhaibani SA, et al. Therapeutic potential of thymoquinone liposomes against the systemic infection of Candida albicans in diabetic mice. PLoS One. 2018;13:e0208951. doi:10.1371/journal.pone.0208951
   PubMed Web of Science ®Google Scholar
• Khan A, Alhumaydhi FA, Alwashmi AS, et al. Diallyl sulfide-mediated modulation of the fatty acid synthase (FASN) leads to cancer cell death in BaP-induced lung carcinogenesis in Swiss mice. J Inflamm Res. 2020;13:1075–1087. doi:10.2147/JIR.S284279
   PubMed Web of Science ®Google Scholar
• Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455–461. doi:10.1002/jcc.21334
   PubMed Web of Science ®Google Scholar
• Fahmy NM, Al-Sayed E, Moghannem S, Azam F, El-Shazly M, Singab AN. Breaking down the barriers to a natural antiviral agent: antiviral activity and molecular docking of Erythrina speciosa extract, fractions, and the major compound. Chem Biodivers. 2020;17:e1900511–e1900511. doi:10.1002/cbdv.201900511
   PubMed Web of Science ®Google Scholar
• Azam F. Elucidation of teicoplanin interactions with drug targets related to COVID-19. Antibiotics. 2021;10:856. doi:10.3390/antibiotics10070856
   Web of Science ®Google Scholar
• Li M, Du C, Guo N, et al. Composition design and medical application of liposomes. Eur J Med Chem. 2019;164:640–653. doi:10.1016/j.ejmech.2019.01.007
   PubMed Web of Science ®Google Scholar
• Ahmed KS, Hussein SA, Ali AH, Korma SA, Lipeng Q, Jinghua C. Liposome: composition, characterisation, preparation, and recent innovation in clinical applications. J Drug Target. 2019;27:742–761. doi:10.1080/1061186X.2018.1527337
   PubMed Web of Science ®Google Scholar
• Anderson M, Omri A. The effect of different lipid components on the in vitro stability and release kinetics of liposome formulations. Drug Deliv. 2004;11:33–39. doi:10.1080/10717540490265243
   PubMed Web of Science ®Google Scholar
• Crommelin DJ. Influence of lipid composition and ionic strength on the physical stability of liposomes. J Pharm Sci. 1984;73:1559–1563. doi:10.1002/jps.2600731118
   PubMed Web of Science ®Google Scholar
• Briuglia M-L, Rotella C, McFarlane A, Lamprou DA. Influence of cholesterol on liposome stability and on in vitro drug release. Drug Deliv Transl Res. 2015;5:231–242. doi:10.1007/s13346-015-0220-8
   PubMed Web of Science ®Google Scholar
• Magarkar A, Dhawan V, Kallinteri P, et al. Cholesterol level affects surface charge of lipid membranes in saline solution. Sci Rep. 2014;4:5005. doi:10.1038/srep05005
   PubMed Web of Science ®Google Scholar
• Papahadjopoulos D, Cowden M, Kimelberg H. Role of cholesterol in membranes. Effects on phospholipid-protein interactions, membrane permeability and enzymatic activity. Biochim Biophys Acta. 1973;330:8–26. doi:10.1016/0005-2736(73)90280-0
   PubMedGoogle Scholar
• Vargason AM, Anselmo AC, Mitragotri S. The evolution of commercial drug delivery technologies. Nature Biomed Eng. 2021;5:951–967. doi:10.1038/s41551-021-00698-w
   PubMed Web of Science ®Google Scholar
• Singh A, Neupane YR, Shafi S, Mangla B, Kohli K. PEGylated liposomes as an emerging therapeutic platform for oral nanomedicine in cancer therapy: in vitro and in vivo assessment. J Mol Liq. 2020;303:112649. doi:10.1016/j.molliq.2020.112649
   Web of Science ®Google Scholar
• Jiménez-López J, Bravo-Caparrós I, Cabeza L, et al. Paclitaxel antitumor effect improvement in lung cancer and prevention of the painful neuropathy using large pegylated cationic liposomes. Biomed Pharmacother. 2021;133:111059. doi:10.1016/j.biopha.2020.111059
   PubMed Web of Science ®Google Scholar
• Mostafa M, Alaaeldin E, Aly UF, Sarhan HA. Optimization and characterization of thymoquinone-loaded liposomes with enhanced topical anti-inflammatory activity. AAPS PharmSciTech. 2018;19:3490–3500. doi:10.1208/s12249-018-1166-1
   PubMed Web of Science ®Google Scholar
• Pain VM, Randall DP, Garlick PJ. Protein synthesis in liver and skeletal muscle of mice bearing an ascites tumor. Cancer Res. 1984;44:1054–1057.
   PubMed Web of Science ®Google Scholar
• Petruzzelli M, Wagner EF. Mechanisms of metabolic dysfunction in cancer-associated cachexia. Genes Dev. 2016;30:489–501. doi:10.1101/gad.276733.115
   PubMed Web of Science ®Google Scholar
• Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51:27–41. doi:10.1016/j.immuni.2019.06.025
   PubMed Web of Science ®Google Scholar
• Sadeck N, Ibrahim BM, Alassal MA. Cytochrome P450-isoenzyme 1A1 in susceptibility to tobacco-related lung cancer. Asian Cardiovasc Thorac Ann. 2014;22:315–318. doi:10.1177/0218492313492987
   PubMedGoogle Scholar
• Miao P, Sheng S, Sun X, Liu J, Huang G. Lactate dehydrogenase a in cancer: a promising target for diagnosis and therapy. IUBMB Life. 2013;65:904–910. doi:10.1002/iub.1216
   PubMed Web of Science ®Google Scholar
• Xie H, Hanai J, Ren J-G, et al. Targeting lactate dehydrogenase-A inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells. Cell Metab. 2014;19:795–809. doi:10.1016/j.cmet.2014.03.003
   PubMed Web of Science ®Google Scholar
• Nikkhoo B, Sigari N, Ghaderi B, et al. Diagnostic utility of adenosine deaminase in serum and bronchoalveolar lavage fluid for screening lung cancer in Western Iran. J Med Biochem. 2013;32:109–115. doi:10.2478/jomb-2013-0011
   Web of Science ®Google Scholar
• Nicco C, Laurent A, Chereau C, Weill B, Batteux F. Differential modulation of normal and tumor cell proliferation by reactive oxygen species. Biomed Pharmacother. 2005;59:169–174. doi:10.1016/j.biopha.2005.03.009
   PubMed Web of Science ®Google Scholar
• Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med. 2010;49:1603–1616. doi:10.1016/j.freeradbiomed.2010.09.006
   PubMed Web of Science ®Google Scholar
• Shadel GS, Horvath TL. Mitochondrial ROS signaling in organismal homeostasis. Cell. 2015;163:560–569. doi:10.1016/j.cell.2015.10.001
   PubMed Web of Science ®Google Scholar
• Forman HJ, Zhang H. Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat Rev Drug Discov. 2021;20:689–709. doi:10.1038/s41573-021-00233-1
   PubMed Web of Science ®Google Scholar
• Pham-Huy LA, He H, Pham-Huy C. Free radicals, antioxidants in disease and health. Int J Biomed Sci. 2008;4:89–96.
   PubMedGoogle Scholar
• Oyewole AO, Birch‐Machin MA. Mitochondria‐targeted antioxidants. FASEB J. 2015;29:4766–4771. doi:10.1096/fj.15-275404
   PubMed Web of Science ®Google Scholar
• Bodduluru LN, Kasala ER, Madhana RM, et al. Naringenin ameliorates inflammation and cell proliferation in benzo(a)pyrene induced pulmonary carcinogenesis by modulating CYP1A1, NFκB and PCNA expression. Int Immunopharmacol. 2016;30:102–110. doi:10.1016/j.intimp.2015.11.036
   PubMed Web of Science ®Google Scholar
• Kasala ER, Bodduluru LN, Barua CC, Gogoi R. Antioxidant and antitumor efficacy of Luteolin, a dietary flavone on benzo(a)pyrene-induced experimental lung carcinogenesis. Biomed Pharmacother. 2016;82:568–577. doi:10.1016/j.biopha.2016.05.042
   PubMed Web of Science ®Google Scholar
• Hudlikar RR, Pai V, Kumar R, et al. Dose-related modulatory effects of Polymeric Black Tea Polyphenols (PBPs) on initiation and promotion events in B(a)P and NNK-induced lung carcinogenesis. Nutr Cancer. 2019;71:508–523. doi:10.1080/01635581.2019.1578389
   PubMed Web of Science ®Google Scholar
• Kaufmann SH, Earnshaw WC. Induction of apoptosis by cancer chemotherapy. Exp Cell Res. 2000;256:42–49. doi:10.1006/excr.2000.4838
   PubMed Web of Science ®Google Scholar
• Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239–257. doi:10.1038/bjc.1972.33
   PubMed Web of Science ®Google Scholar
• Refaat H, Mady FM, Sarhan HA, Rateb HS, Alaaeldin E. Optimization and evaluation of propolis liposomes as a promising therapeutic approach for COVID-19. Int J Pharm. 2021;592:120028. doi:10.1016/j.ijpharm.2020.120028
   PubMed Web of Science ®Google Scholar
• Baldi A, Chaudhary M, Sethi S, Abhiav Chandra R, Madan J, Madan J. Armamentarium of nanoscaled lipid drug delivery systems customized for oral administration: in silico docking patronage, absorption phenomenon, preclinical status, clinical status and future prospects. Colloids Surf B Biointerfaces. 2018;170:637–647. doi:10.1016/j.colsurfb.2018.06.061
   PubMed Web of Science ®Google Scholar